For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Heparin, also known as unfractionated heparin (UFH), is medication which is used as an anticoagulant (blood thinner). Specifically it is used to treat and prevent deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It is also used in the treatment of heart attacks and unstable angina.[3] It is given by injection into a vein.Other uses include inside test tubes and kidney dialysis machines.Common side effects include bleeding, pain at the injection site, and low blood platelets.Serious side effects include heparin induced thrombocytopenia. Greater care is needed in those with poor kidney function.Heparin appears to be relatively safe for use during pregnancy and breastfeeding.Heparin is a naturally occurring glycosaminoglycan.
The Sodium Heparin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Sodium Heparin industry, and breaks down according to the type, application, and consumption area of Sodium Heparin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Sodium Heparin in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Sodium Heparin market covered in Chapter 11:
Aspen Oss
Pfizer
Qianhong Bio-pharma
Hepalink
Opocrin
Changshan Pharm
In Chapter 3, on the basis of types, the Sodium Heparin market from 2018 to 2028 is primarily split into:
Heparin Sodium
Heparin Calcium
Other
In Chapter 4, on the basis of applications, the Sodium Heparin market from 2018 to 2028 covers:
UFH
LMWH
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028